Deborah Phippard is a pharma industry veteran and expert at biomarker-driven clinical trial design and execution. She led biomarker and drug development programs for pharmaceutical and diagnostics companies, as well as the National Institutes of Health. She has also spearheaded the discovery of pharmacodynamic biomarkers and novel targets for inflammatory disease therapy.